Sildenafil citrate, commonly known by the brand name, is a prescription-only medicine used to treat erectile dysfunction (ED) in adult men. It works by improving blood flow to the penis, helping to achieve and maintain an erection during sexual activity.
Sildenafil is available in 25mg, 50mg, and 100mg strengths.
Sildenafil has been shown to be effective in up to 80% of men with ED, with effects typically noticeable within 30 to 60 minutes, and lasting for up to 4–5 hours.
Common side effects include:
Less common but serious effects include visual disturbances, hearing changes, or prolonged erections. Seek medical attention if severe or persistent side effects occur.
Sildenafil should not be used by those:
Inform your doctor of all medications and supplements before use. Interactions may occur with:
Avoid excessive alcohol while taking sildenafil, as it can lower blood pressure and increase side effect risk. Use with caution if you have any heart-related conditions.
Sildenafil is available by prescription only in the UK.
Don’t let ED affect your confidence or relationships. Buy Sildenafil tablets online today and experience more satisfying erections — securely, discreetly, and from our trusted UK-regulated pharmacy.
✅ Free online consultation✅ Fast UK delivery✅ Discreet packaging✅ GPhC-regulated
now and get back to enjoying intimacy with confidence.
Store Notice: Orders placed after 11:00 AM on Friday, 23 May 2025 will be processed on the next working day, Tuesday, 27 May 2025, due to the bank holiday weekend. Thank you for your understanding.
NewThe following products are products from now.100mg
The FDA has issued a warning regarding the use of sildenafil (Viagra®) to treat erectile dysfunction.
The agency said the drug is not recommended for use as the FDA has found it does not affect blood flow and heart rate, but for the use of erectile dysfunction.
This is because sildenafil is a drug that has a low affinity for the brain and thus has the potential to cause significant side effects. The potential adverse reactions associated with sildenafil include nausea, dizziness, headaches, visual disturbances, blurred vision, and fatigue.
Sildenafil was found to be associated with an increased risk of stroke and heart attack, according to the FDA.
However, the FDA had not identified the drug’s side effects and issued no warning for those side effects. However, the agency said it is reviewing the matter.
The FDA will continue to monitor the safety of the drug and the safety of other drugs in the market.
The FDA said the company has not stopped testing the drug as a treatment for erectile dysfunction. In an email, the company said the drug should be used only when directed by a doctor.
The FDA issued a warning regarding the use of sildenafil to treat erectile dysfunction.
This is because the drug is a drug that has a low affinity for the brain and thus has the potential to cause significant side effects.
The FDA has issued a warning for the use of sildenafil to treat erectile dysfunction.
NEW YORK (Reuters Health) --, which has a portfolio of five drug companies, is looking at a deal with San Francisco biotech firm San Leandro Inc. to acquire three drugs that it acquired from drugmakers GlaxoSmithKline Plc and Sanofi-Aventis Plc.
"We are very excited and our hope is that our strategy for the acquisition of our new portfolio of products will help us to continue to advance our drug pipeline, while ensuring that our existing portfolio of drugs is as efficient and effective as possible," said Jeffrey Kindler, president of San Leandro and a partner in the San Francisco-based drug portfolio. The company, which makes Viagra, said it had agreed to buy three other drug companies and it will pay $1.3 billion to acquire two more.
The deals are a step in the right direction, Kindler said, because they represent a major step forward in the company's long-term strategy, which will likely require a significant shift in its focus to developing more efficient medicines for medical conditions.
He noted that San Leandro, which is based in San Francisco, has a portfolio of three drugs in particular, including a novel oral contraceptive that will help men with erectile dysfunction, and a new anti-cancer drug that has been developed and marketed by AstraZeneca Pharmaceuticals LP and Bayer AG, in the United States and worldwide.
The three companies are among the largest drug companies in the world and are set to be the largest pharmaceutical company in the world with revenues in excess of $1 billion in the next six to 12 years.
San Leandro is a research-driven biopharmaceutical company that provides high-quality, affordable healthcare products at reduced costs, with a focus on improving patient health. The San Leandro-based companies are the most-researched group of pharmaceutical companies in the United States, with a combined revenue of $750 billion.
"The opportunity to acquire one of the most innovative biopharmaceutical companies in the world is very attractive," said Peter Wieland, president of San Leandro. "The ability to invest in high-quality biopharmaceutical companies in a market where we can get the highest standards of care is a major win for San Leandro. It will be an exciting time for San Leandro, a company that is committed to a successful, long-term business relationship."
The deal with San Leandro was announced in a telephone conversation with GlaxoSmithKline's board of directors, according to a statement from GlaxoSmithKline, which represents San Leandro. San Leandro, a leading player in the biopharma sector, has a portfolio of four products in particular and a team of six. San Leandro's portfolio includes two new drugs: a novel oral contraceptive called lopinavir/ritonavir, and a new drug that has been developed and marketed by AstraZeneca and Bayer.
San Leandro said that it had also reached an agreement with AstraZeneca to acquire the remaining three drug companies from the existing San Leandro portfolio and that it would pay $1.3 billion to acquire two additional drug companies.
"We believe that the acquisition of the companies we have now will help us to continue our long-term strategy, which is to provide greater affordability and efficiency to our customers," said San Leandro chairman and chief executive officer Ian Read.
San Leandro said the company had agreed to acquire one of the largest drug companies in the world and that it would pay $1.3 billion to buy two additional companies.
The companies, both San Leandro and GlaxoSmithKline, are owned by GlaxoSmithKline, which is based in San Francisco. The San Leandro-based companies are one of the largest pharmaceutical companies in the world and are set to be the largest pharmaceutical company in the world with revenues in excess of $1 billion in the next six to 12 years.
The three companies are among the largest drug companies in the world and are set to be the largest pharmaceutical company in the world with revenues in excess of $1.3 billion in the next six to 12 years. The San Leandro-based companies are set to be the largest pharmaceutical company in the world with revenues in excess of $1.3 billion in the next six to 12 years.
PIL A VIAGRA - MEDICINPIL A VIAGRA- Efron and Pfizer (Pfizer) have signed a long-lasting agreement that would create a new, independent company (PIL) that would be the first pharmaceutical company to produce the first bioequivalent drug approved by the US Food and Drug Administration (FDA).
Pfizer has been developing and selling a range of different types of impotence drugs for many years, including its popular impotence drug Viagra. Viagra is a type of erectile dysfunction drug, and it has been approved for use in men only. However, it is widely used as an over-the-counter treatment for erectile dysfunction and does not work in the same way as other impotence drugs. Viagra is also available in generic form. PIL A VIAGRA would be a complete new company in a long-term relationship. It is important to note that Pfizer is not the first company to develop generic impotence drugs. In fact, there have been several attempts to create a similar, more cost-effective treatment option.
PIL B- Pfizer has signed an agreement with a company known as ‘PIL’, which will have its primary and secondary patents up and running in the second half of 2024, which will allow Pfizer to launch its first drug in the US in 2017. Pfizer will also have its US headquarters in the UK. A separate agreement, ‘PILC’, will be reached after the latter has completed its initial phase 3 trials and has developed its first drug, a new medication that has been approved for use in adults. Pfizer will also be able to introduce its second drug, Viagra, in late 2017.
PIL C will be a fully-registered company, with a primary and secondary patent, which will expire in 2023. The company will have its US headquarters in the UK, where it will also have its US headquarters in the UK. Pfizer will also have its UK headquarters in the US.
PIL C. Efron- Pfizer will also have its US headquarters in the UK, where it will have its US headquarters in the US. The company will also have its US headquarters in the United Kingdom. The company will have its US headquarters in the UK.
The Pfizer-Pil C agreement is a long-term partnership, as both companies are members of the same global pharmaceutical manufacturing and distribution organization (PMMO). Pfizer is one of the world’s leading pharmaceutical companies. It is a leading name in the industry, with over 80 years of experience in developing and manufacturing a wide range of pharmaceutical products.
PIL C is a new company, which would create a new company in a long-term relationship. It would create a new company in a new country. Pfizer would be one of the world’s leading pharmaceutical companies.
PIL B.- Pfizer is currently the only company that would become part of the new Pfizer-Pil C. Efron agreement. Pfizer is the first pharmaceutical company to be formed in a long-term relationship. It would create a new company.
PIL B would be the first new company, and would be the first company formed in a new country. It would be a new company in a new country, as far as its US headquarters would be in the US.
Amgen- Pfizer has been developing an innovative treatment for erectile dysfunction and is in discussions with a number of potential companies that could develop this treatment. The company has a US headquarters in the UK, which would be located in the US, and will have a US headquarters in Canada. Pfizer is already working with Merck and Company to develop and commercialise its next-generation version, Viagra Connect, for the treatment of erectile dysfunction.
The new Pfizer-Pil C. Amgen agreement would be the largest long-term partnership in the US. Pfizer would be the first pharmaceutical company to be formed in a new country. Pfizer would also be one of the world’s leading pharmaceutical companies.
As far as the other companies, Pfizer is one of the world’s leading pharmaceutical companies. Pfizer has a US headquarters in the UK, and the US would be in the UK.
VIDEOPfizer- Pfizer is currently the only company to be part of the new Pfizer-Pil C. Amgen agreement.
In the United States, the Food and Drug Administration (FDA) regulates the use of condoms in all sexual activity and other drugs. This regulation, in turn, can affect men’s sexual health and the ability of men to get or maintain an erection. In order to obtain the medication, men must be sexually aroused. This can be done either before or after intercourse. If you’ve been sexually aroused, then you can take an oral medication that contains sildenafil, an FDA approved erectile dysfunction medication. It’s important to take these pills on an empty stomach and swallow them whole with a full glass of water. This medication should be taken only when sexually stimulated. You should not take this medication on its own or with alcohol. The medication should not be taken with grapefruit juice. Grapefruit juice is also not safe and should be avoided if you’re a woman. In conclusion, the FDA regulates the use of condoms in all sexual activity and other drugs. The FDA regulates the use of erectile dysfunction drugs like Viagra, Cialis, and Levitra, and it should not be used in conjunction with sexual activity. If you need to use an erectile dysfunction medication, then you can take it with or without sexual stimulation. You should never take a pill with a heavy meal or alcohol. Your doctor may recommend using a Viagra medication before a sexual activity, or you may need to take the medication with a heavy meal or alcohol. It’s important to take these medications at the same time each day. Do not take your medication with grapefruit juice.
You should not take your medication with grapefruit juice.
Stade de France Pharmacy